Results 311 to 320 of about 98,962 (385)

Maximizing Efficacy of Cancer Nanovaccines and Immune Cells Landscape in Responders and Non-Responders to Immunotherapy. [PDF]

Adv Sci (Weinh)
Xu X, Diao L, Wang J, Zhu A, Chen X, Zheng Y, Liu Y, Hu K, Zhu J, Ding C, Li C, Pan Y, Zhao J, Liu M.   +13 more
europepmc   +1 more source

Thoughts on Supervision over Biopharmaceuticals in China

, 2009
Dehua Yang, Dong Li, Juan Liu
openalex   +2 more sources

Upfront payments to venture‐backed startups in technology alliances: Bargaining effects of VC affiliations

Strategic Entrepreneurship Journal, EarlyView.
Abstract Research Summary Upfront payments are important financial resources startups seek to negotiate in technology alliances. This study unpacks how venture‐backed startups can benefit from their VC affiliations and obtain better payments. We develop a bargaining framework and argue that VCs can strengthen venture‐backed startups' hand in alliance ...
Ramakrishna Devarakonda, Shivaram Devarakonda, Jeffrey J. Reuer   +2 more
wiley   +1 more source

Dual Blocking of IL17A and IL36R for the Treatment of Refractory Hidradenitis Suppurativa: A Case Report. [PDF]

Biologics
Yu Y, Li J, Liu H, Sun Y, Zhang F.
europepmc   +1 more source

From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry

, 2010
Valérie Sabatier, Vincent Mangematin, Tristan Rousselle   +2 more
openalex   +2 more sources

The extent and drivers of internal agglomeration of U.S. multi‐unit firms

Strategic Management Journal, EarlyView.
Abstract Research Summary This paper examines the extent and determinants of internal agglomeration—the spatial clustering of establishments within firms. It introduces a novel methodology that benchmarks a firm's spatial footprint against that of comparable stand‐alone firms, yielding a firm‐level measure of internal agglomeration.
Juan Alcácer, Jasmina Chauvin
wiley   +1 more source

In Silico Evaluation of the Biopharmaceutical and Pharmacokinetic Behavior of Metronidazole from Coated Colonic Release Matrix Tablets. [PDF]

Pharmaceutics
Arévalo-Pérez R, Maderuelo C, Lanao JM.   +2 more
europepmc   +1 more source

PEARL: Protein Eluting Alginate with Recombinant Lactobacilli

Small, EarlyView.
Probiotic lactobacilli meet engineered living materials: This study introduces PEARL (protein eluting alginate with recombinant lactobacilli), an innovative engineered living material combining Lactiplantibacillus plantarum and alginate beads for controlled protein release.
Varun Sai Tadimarri, Marc Blanch‐Asensio, Ketaki Deshpande, Jonas Baumann, Carole Baumann, Rolf Müller, Sara Trujillo, Shrikrishnan Sankaran   +7 more
wiley   +1 more source

Formulation of Recombinant Therapeutic Proteins: Technological Innovation, Regulations, and Evolution Towards Buffer-Free Formulations. [PDF]

Pharmaceutics
Bas TG.
europepmc   +1 more source

Nasal Delivery of mRNA Using Thermoresponsive Gellable Aqueous Biphasic Systems

Small, EarlyView.
Nasal delivery of mRNA using gellable aqueous biphasic systems (ABS) represents a noninvasive alternative while reducing the need for trained professionals and cold chain storage. Composed of gelatin, PEG, and water, these thermoresponsive hydrogels ensure controlled mRNA delivery and prolonged retention at the nasal mucosa, improving transfection ...
Bojan Kopilovic, Nabila Laroui, João A.P. Coutinho, Chantal Pichon, Mara G. Freire   +4 more
wiley   +1 more source